Nucleotide excision repair in the test tube. by Jaspers, N.G.J. (Nicolaas) & Hoeijmakers, J.H.J. (Jan)
N.G.J. JASPERS AND J.H.J. HOEIJMAKERS DNA REPAIR 
Nucleotide excision-repair in the test tube 
The eu karyotic nucleotide excision-repair pathway has been reconstituted 
in vitro, an achievement that should hasten the full enzymological 
characterization of this highly complex DNA-repair pathway. 
All living organisms have evolved mechanisms to cope 
with the problem of genomic instabhty. Cells have a 
number of different mechanisms for repairing the various 
types of damage - resulting from errors of internal meta- 
bolism or the action of external agents - that their DNA 
is prone to. Many of these mechanisms are relatively sim- 
ple and speciahzed for the repair of strictly defined types 
of DNA lesions: those dealing with strand mismatches 
or small base adducts, for example. The nucleotide exci- 
sion-repair (NER) pathway, however, can recognize a 
broad spectrum of heh-distorting lesions, mostly gener- 
ated by environmental DNA-damaging agents, such as 
ultraviolet (UV) light. In eukaryotes, this versatility is 
accomplished by intricate interactions between many pro- 
teins, which mediate the excision and replacement of a 
single-strand patch substantially larger than the structurally 
affected DNA region itself. The basic features of NER 
have remained unchanged throughout eukaryotic evolu- 
tion, h m  simple yeasts up to hlgher mammals, and many 
parallels extend even to prokaryotes such as Escherichia coli. 
The complexity of eukaryotic NER is reminiscent of the 
other fundamental DNA metabolic processes - transcrip- 
tion, replication and recombination - and mutual inter- 
actions between these processes are now being uncovered. 
The classical biochemical approach to dissecting such 
processes involves the separation of the individual compo- 
nents and their reconstitution to a fully operative system. 
While simplified in vitro systems for basic transcription and 
replication have been available for some time, the recon- 
stitution of NER has just recently been reported by 
Aboussekra et al. [I]. This delay is remarkable as, unlike 
replication and transcription, NER is only essential in the 
presence of environmental stress, so that mutants afTected 
in this system can readily be identified and genetic analysis 
is possible. The well-known human inherited disorders 
xeroderma pigmentosum (XP), Cockayne's syndrome 
(CS) and trichothiodystrophy are caused by mutations, 
defining at least ten complementation groups, affecting 
NER; many other, less well-known, NER mutants have 
been identified in yeast and cultured mammalian cells. 
The first attempts to set up a mammalian cell-free NER 
system date back to 1976 [2]. However, this and other 
early systems lacked stability, reproducibhty or specifi- 
city. Twelve years later, and twenty years after Cleaver's 
discovery that NER is defective in cells from XP patients, 
Wood et al. [3], followed independently by Sibghat- 
Ullah et al. [4], described how carefully isolated mam- 
mahan cell extracts can repair damage on simple plasmid 
DNAs. The conditions appeared to mimic the NER sys- 
tem rather closely, as most of the factors affected in the 
known mammahan NER mutants were required. Extracts 
from different mutants that complement each other in 
vivo - that is, after cell fusion - were generally also able 
to do so in the cell-free system. 
The in vitro assay was soon successfully exploited for a 
number of enzymological advances. These included the 
isolation of the XPA, XPC and XPG proteins [5-71, the 
separation of the incision and excisiodgap-filling steps, 
the discovery of the involvement of the replication fac- 
tors PCNA (proliferating cell nuclear antigen) and RPA 
[8-111, the identification of the ERCCl/XPF enzyme 
complex [12,13] and the sizing of the excised patch to 
27-29 nucleotides [14]. From 1984 on [15], most of the 
NER genes were gradually cloned by painstaking gene- 
transfer experiments carried out using the mutant cell 
cultures (reviewed in [16]). In adhtion, the human multi- 
protein TFIIH basal transcription factor complex was 
isolated and unexpectedly found to harbour at least three 
known repair proteins [17,18]. It is mainly the combina- 
tion of these developments that has made the full in vitro 
reconstitution of NER possible. 
The approach used by Aboussekra et al. [I] and, indepen- 
dently but worked out in less detail, by Mu et al. [19] was 
as classical as it was effective. First, a repair-competent 
mamrnahan extract was fiactionated into at least eight 
parts using standard chromatographic procedures. Then, 
these fractions were tested one by one for the presence of 
known repair enzymes. Finally, the fractions were replaced 
by purified enzyme preparations, either derived from 
individual repair genes overexpressed in bacterial or insect 
cells, or from detailed classical purification protocols 
starting with HeLa nuclear extracts. 
The initial stages of NER, comprising the damage recog- 
nition step and a dual incision around the lesion, were 
found to require the single proteins XPA and XPG, 
and the multi-protein complexes TFIIH, RPA (hSSB), 
ERCC1 /XPF and XPC/HHR23B. The XPE-related 
protein UV-DDB acted as a dispensable stimulator. A 
new essential factor IF7 (incision factor 7), as yet only 
partially characterized, was also identified. Completion of 
the NER reaction, which involves patch-displacement, 
gap-filling and religation, could be accomplished by 
DNA polymerase E and ligase I, in combination with the 
accessory replication factors PCNA, RPA and RF-C. 
Interestingly, this final stage could be performed just as 
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well by a combination of the E. coli DNA polymerase I
Klenow fragment and ligase.
A total of between 25 and 30 proteins (summarized in
Table 1) are minimally required to reconstitute the full
NER reaction; this is, however, just an estimate, as some
uncertainties remain. For instance, the TFIIH prepara-
tion used in the experiments contained at least six poly-
peptides, known as the 'core complex', which are also
required to support in vitro transcription. It is, however,
very likely that (minor) accessory factors present in this
preparation, such as cyclin-dependent kinase CDK7 [20],
are also involved in NER. As a second example, the
composition of the ERCC1/XPF complex is still uncer-
tain, as it could not be purified to homogeneity using
classical chromatography, a failure also experienced by
two other groups [19,21]. Besides ERCC1 and an
unknown 110 kD protein, identified by South-western
blotting [1] and immunoprecipitation [21], the complex
carries the complementing activities of the XPF and
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ERCC11 mutants [12,13]. Finally, the newly identified
factor IF7 also remains uncharacterized.
The in vitro reconstitution of NER clearly opens the
door to further dissection of its individual steps, their
order and the protein-protein interactions involved. In
the years to come, our knowledge of mammalian NER
can be expected to become at least as detailed as that of
the much simpler uvrABCD excinuclease system of
E. coli. Despite all these promises for the future, adapting
the basic NER reaction to simplified in vitro conditions
has its price. Cells repair the transcribed strand of their
active genes much faster than the remainder of the
genome, by an NER subpathway called transcription-
coupled repair (TCR). In patients with CS, TCR is
impaired, but the global NER facility is unaffected [22].
The gene products CSA and CSB are not required for
the reconstituted in vitro NER reaction, and extracts of
CS mutant cells (both human and hamster) have normal
NER activity. This implies that the test-tube conditions
selectively reflect the global repair subpathway, which is
not entirely unexpected as the damaged plasmid used as
the substrate is not transcribed in the experimental con-
ditions. It also fits with the need for the XPC/HHR23B
complex, which is known to be essential for the global
NER subpathway only [22].
Recent attempts to set up a repair assay with a substrate
carrying an active transcription unit and ribonucleotides
added in the reaction mixture have not yet resulted in
a clear-cut CSB-dependence or CSA-dependence. It
appears that much more is needed to reproduce the
TCR subpathway in vitro; presumably the chromatin
structure of the repair substrate has to be taken into
account as well. SV40 minichromosomes with a partially
intact chromatin structure can be repaired in vitro [6],
but this repair activity also appears largely to reflect the
global subpathway, as it is strongly dependent on XPC/
HHR23B. As a matter of fact, the human homologs of
the yeast global repair proteins RAD7 and RAD16
could not be traced in the in vitro system yet.
Most of the NER proteins exist as stable complexes, but
recent work has suggested that a minor fraction may
come in the form of a multi-protein supercomplex, ten-
tatively called the 'repairosome' [23]. The reconstitution
studies however, indicate that such a structure, if present
in the in vitro conditions, can be readily assembled from
and separated into its individual components. In the near
future, detailed work with the reconstituted system will
undoubtedly reveal the significance of the appealing
repairosome concept.
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